Oct 22, 2019

By Christine Ross

Share on

It’s being called a landmark step in the search for a treatment for the most common form of dementia.

This week, drug company Biogen Inc.plans to ask for U-S federal approval for a medicine to treat early Alzheimer’s disease. The drug, aducanumab, helps the body clear harmful plaques from the brain. The discovery comes as a bit of a surprise, because Biogen had stopped two studies of the drug earlier this year when partial results suggested it was not likely to be successful. But the company says further investigation suggests patient who took a higher dose of the medication had less of a decline in thinking skills. The approval processes could take a year or two and if successful, the company hopes to initially offer the drug to patients previously enrolled in clinical studies of the drug.

Advertise With Us

To learn about advertising opportunities with Zoomer Radio use the link below:

Join Our Fan Club
Coverage Area
Downtown Toronto
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
ZoomerRadio Logo

Recently Played: